Related Experiment Video
Updated: Aug 15, 2026

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
Resistance to antibiotics: are we in the post-antibiotic era?
1Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA. aao@lilly.com
Abstract:
Serious infections caused by bacteria that have become resistant to commonly used antibiotics have become a major global healthcare problem in the 21st century. They not only are more severe and require longer and more complex treatments, but they are also significantly more expensive to diagnose and to treat. Antibiotic resistance, initially a problem of the hospital setting associated with an increased number of hospital-acquired infections usually in critically ill and immunosuppressed patients, has now extended into the community causing severe infections difficult to diagnose and treat. The molecular mechanisms by which bacteria have become resistant to antibiotics are diverse and complex. Bacteria have developed resistance to all different classes of antibiotics discovered to date. The most frequent type of resistance is acquired and transmitted horizontally via the conjugation of a plasmid. In recent times new mechanisms of resistance have resulted in the simultaneous development of resistance to several antibiotic classes creating very dangerous multidrug-resistant (MDR) bacterial strains, some also known as "superbugs". The indiscriminate and inappropriate use of antibiotics in outpatient clinics, hospitalized patients and in the food industry is the single largest factor leading to antibiotic resistance. In recent years, the number of new antibiotics licensed for human use in different parts of the world has been lower than in the recent past. In addition, there has been less innovation in the field of antimicrobial discovery research and development. The pharmaceutical industry, large academic institutions or the government are not investing the necessary resources to produce the next generation of newer safe and effective antimicrobial drugs. In many cases, large pharmaceutical companies have terminated their anti-infective research programs altogether due to economic reasons. The potential negative consequences of all these events are relevant because they put society at risk for the spread of potentially serious MDR bacterial infections.
Insights
Antibiotic resistance is a growing global threat, leading to severe infections and increased healthcare costs. Inappropriate antibiotic use and declining R&D investment exacerbate this crisis, risking widespread multidrug-resistant bacterial infections.
Area of Science:
- Microbiology
- Infectious Diseases
- Public Health
Background:
- Serious bacterial infections resistant to common antibiotics are a major global health challenge.
- Antibiotic resistance has spread from hospitals to communities, causing severe and difficult-to-treat infections.
- Multidrug-resistant (MDR) bacterial strains, or "superbugs," pose a significant threat due to diverse and complex resistance mechanisms.
Purpose of the Study:
- To highlight the escalating problem of antibiotic resistance.
- To discuss the mechanisms and spread of antibiotic resistance.
- To underscore the critical need for new antibiotic development and responsible usage.
Main Methods:
- Review of current scientific literature on antibiotic resistance mechanisms.
- Analysis of trends in antibiotic resistance and new drug development.
- Examination of factors contributing to the rise of multidrug-resistant bacteria.
Main Results:
- Bacteria exhibit diverse resistance mechanisms, including horizontal gene transfer via plasmids.
- Newer resistance mechanisms lead to multidrug-resistant strains, increasing infection severity and treatment complexity.
- There is a concerning decline in the development and licensing of new antibiotics globally.
Conclusions:
- Indiscriminate antibiotic use in clinical and agricultural settings is the primary driver of resistance.
- Insufficient investment in antimicrobial research and development by pharmaceutical companies and governments is hindering the creation of new drugs.
- The societal risk of untreatable MDR bacterial infections is substantial due to these combined factors.
Related Concept Videos
Development of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Antibiotic Selection
Clinical Significance of Antibiotic Resistance
Microbiota Modulation by Antibiotics
Antimicrobial Effectiveness
